Literature DB >> 16112647

Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.

Ningxi Zhu1, Lubing Gu, Harry W Findley, Muxiang Zhou.   

Abstract

The eukaryotic initiation factor 4E (eIF4E) plays important roles in transformation and cancer progression. It is frequently overexpressed in malignant cells, one mechanism of which is through transcriptional activation by c-myc. Here, we report that high level of eIF4E expression and its tumorigenicity could be alternatively associated with defects of p53, since we found that induction of wt-p53 repressed eIF4E expression. Gene transfection of p53 inhibited eIF4E promoter activity, while inactivation of p53 either by mutation or by over-expression of MDM2 resulted in stimulation of eIF4E promoter activity. We demonstrated that p53-repression of eIF4E was regulated by c-myc. The wt-p53 can physically bind to c-myc, which inhibited binding of c-myc to eIF4E promoter and c-myc-stimulated promoter activity. These results suggest that the expression of eIF4E is reciprocally regulated by p53 and c-myc, and loss of p53-mediated control over c-myc-dependent transactivation of eIF4E may represent a novel mechanism for eIF4E-mediated neoplastic transformation and cancer progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112647     DOI: 10.1016/j.bbrc.2005.08.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Authors:  Kerry Byrnes; Stephen White; Quyen Chu; Carol Meschonat; Herbert Yu; Lester W Johnson; Arrigo Debenedetti; Fleurette Abreo; Richard H Turnage; John C McDonald; Benjamin D Li
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 2.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

3.  Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.

Authors:  Jin Zhang; Seong-Jun Cho; Limin Shu; Wensheng Yan; Teri Guerrero; Michael Kent; Katherine Skorupski; Hongwu Chen; Xinbin Chen
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

Review 4.  The oncogene eIF4E: using biochemical insights to target cancer.

Authors:  Martin Carroll; Katherine L B Borden
Journal:  J Interferon Cytokine Res       Date:  2013-03-08       Impact factor: 2.607

Review 5.  Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?

Authors:  Katherine L B Borden
Journal:  Biochim Biophys Acta       Date:  2008-06-18

6.  Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.

Authors:  Tzu-Hao Cheng; Po-Kuei Hsu; Anna Fen-Yau Li; I-Chun Hung; Min-Hsiung Huang; Han-Shui Hsu
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-02       Impact factor: 4.553

7.  Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.

Authors:  Ivan Topisirovic; Nadeem Siddiqui; Slobodanka Orolicki; Lucy A Skrabanek; Mathieu Tremblay; Trang Hoang; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

8.  The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.

Authors:  F Hariri; M Arguello; L Volpon; B Culjkovic-Kraljacic; T H Nielsen; J Hiscott; K K Mann; K L B Borden
Journal:  Leukemia       Date:  2013-03-07       Impact factor: 11.528

Review 9.  One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.

Authors:  Levin Böhlig; Karen Rother
Journal:  J Biomed Biotechnol       Date:  2011-03-08

10.  eIF4E is a central node of an RNA regulon that governs cellular proliferation.

Authors:  Biljana Culjkovic; Ivan Topisirovic; Lucy Skrabanek; Melisa Ruiz-Gutierrez; Katherine L B Borden
Journal:  J Cell Biol       Date:  2006-10-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.